ARVN
Price
$7.55
Change
-$0.25 (-3.21%)
Updated
Jun 27 closing price
Capitalization
551.45M
32 days until earnings call
CTXR
Price
$1.33
Change
-$0.00 (-0.00%)
Updated
Jun 27 closing price
Capitalization
17.1M
Interact to see
Advertisement

ARVN vs CTXR

Header iconARVN vs CTXR Comparison
Open Charts ARVN vs CTXRBanner chart's image
Arvinas
Price$7.55
Change-$0.25 (-3.21%)
Volume$2.93M
Capitalization551.45M
Citius Pharmaceuticals
Price$1.33
Change-$0.00 (-0.00%)
Volume$26.95K
Capitalization17.1M
ARVN vs CTXR Comparison Chart in %
Loading...
ARVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CTXR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ARVN vs. CTXR commentary
Jun 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARVN is a Hold and CTXR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 29, 2025
Stock price -- (ARVN: $7.55 vs. CTXR: $1.33)
Brand notoriety: ARVN and CTXR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ARVN: 114% vs. CTXR: 1%
Market capitalization -- ARVN: $551.45M vs. CTXR: $17.1M
ARVN [@Biotechnology] is valued at $551.45M. CTXR’s [@Biotechnology] market capitalization is $17.1M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARVN’s FA Score shows that 1 FA rating(s) are green whileCTXR’s FA Score has 1 green FA rating(s).

  • ARVN’s FA Score: 1 green, 4 red.
  • CTXR’s FA Score: 1 green, 4 red.
According to our system of comparison, CTXR is a better buy in the long-term than ARVN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARVN’s TA Score shows that 3 TA indicator(s) are bullish while CTXR’s TA Score has 5 bullish TA indicator(s).

  • ARVN’s TA Score: 3 bullish, 4 bearish.
  • CTXR’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, CTXR is a better buy in the short-term than ARVN.

Price Growth

ARVN (@Biotechnology) experienced а +1.55% price change this week, while CTXR (@Biotechnology) price change was +23.15% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

ARVN is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ARVN($551M) has a higher market cap than CTXR($17.1M). ARVN YTD gains are higher at: -60.589 vs. CTXR (-66.750). CTXR has higher annual earnings (EBITDA): -42.77M vs. ARVN (-89.3M). ARVN has more cash in the bank: 954M vs. CTXR (26.4K). CTXR has less debt than ARVN: CTXR (932K) vs ARVN (10.5M). ARVN has higher revenues than CTXR: ARVN (427M) vs CTXR (0).
ARVNCTXRARVN / CTXR
Capitalization551M17.1M3,222%
EBITDA-89.3M-42.77M209%
Gain YTD-60.589-66.75091%
P/E RatioN/AN/A-
Revenue427M0-
Total Cash954M26.4K3,613,636%
Total Debt10.5M932K1,127%
FUNDAMENTALS RATINGS
ARVN vs CTXR: Fundamental Ratings
ARVN
CTXR
OUTLOOK RATING
1..100
6649
VALUATION
overvalued / fair valued / undervalued
1..100
17
Undervalued
9
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
8698
PRICE GROWTH RATING
1..100
6538
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CTXR's Valuation (9) in the Pharmaceuticals Major industry is in the same range as ARVN (17) in the Biotechnology industry. This means that CTXR’s stock grew similarly to ARVN’s over the last 12 months.

CTXR's Profit vs Risk Rating (100) in the Pharmaceuticals Major industry is in the same range as ARVN (100) in the Biotechnology industry. This means that CTXR’s stock grew similarly to ARVN’s over the last 12 months.

ARVN's SMR Rating (86) in the Biotechnology industry is in the same range as CTXR (98) in the Pharmaceuticals Major industry. This means that ARVN’s stock grew similarly to CTXR’s over the last 12 months.

CTXR's Price Growth Rating (38) in the Pharmaceuticals Major industry is in the same range as ARVN (65) in the Biotechnology industry. This means that CTXR’s stock grew similarly to ARVN’s over the last 12 months.

CTXR's P/E Growth Rating (100) in the Pharmaceuticals Major industry is in the same range as ARVN (100) in the Biotechnology industry. This means that CTXR’s stock grew similarly to ARVN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ARVNCTXR
RSI
ODDS (%)
N/A
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
83%
Momentum
ODDS (%)
Bearish Trend 3 days ago
87%
Bullish Trend 3 days ago
84%
MACD
ODDS (%)
N/A
N/A
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 3 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
72%
Bullish Trend 3 days ago
80%
Advances
ODDS (%)
N/A
Bullish Trend 3 days ago
85%
Declines
ODDS (%)
Bearish Trend 10 days ago
82%
Bearish Trend 14 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
84%
Aroon
ODDS (%)
Bullish Trend 3 days ago
72%
Bullish Trend 3 days ago
75%
View a ticker or compare two or three
Interact to see
Advertisement
ARVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CTXR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
XIN1.76N/A
+0.28%
Xinyuan Real Estate Co Ltd
CFFI62.07-0.12
-0.19%
C&F Financial Corp
NNI120.56-0.74
-0.61%
Nelnet
CHPT0.74-0.02
-2.01%
ChargePoint Holdings
BBDO2.53-0.14
-5.24%
Banco Bradesco SA

ARVN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ARVN has been loosely correlated with ATXS. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if ARVN jumps, then ATXS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARVN
1D Price
Change %
ARVN100%
-3.14%
ATXS - ARVN
39%
Loosely correlated
N/A
ERAS - ARVN
39%
Loosely correlated
N/A
GMAB - ARVN
38%
Loosely correlated
-1.11%
TECH - ARVN
37%
Loosely correlated
-1.82%
CRGX - ARVN
36%
Loosely correlated
-0.71%
More

CTXR and

Correlation & Price change

A.I.dvisor indicates that over the last year, CTXR has been loosely correlated with EYEN. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if CTXR jumps, then EYEN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CTXR
1D Price
Change %
CTXR100%
N/A
EYEN - CTXR
36%
Loosely correlated
+39.99%
ALEC - CTXR
29%
Poorly correlated
-1.33%
KLTO - CTXR
29%
Poorly correlated
-42.39%
VYGR - CTXR
29%
Poorly correlated
-0.34%
ARVN - CTXR
28%
Poorly correlated
-3.14%
More